Yahoo Web Search

Search results

    • Q1 2024 Iterum Therapeutics PLC Earnings Call

      Thomson Reuters StreetEvents via Yahoo Finance· 1 day ago

      ...plans, strategies, and prospects for our business, including the development, therapeutic, and market potential of oral sulopenem, our ability to address the deficiencies set out in the complete response letter received from the FDA in July 2021, the expected timing of review of the resubmitted...